Log In
Print
BCIQ
Print
Print this Print this
 

CAL-129

  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionOral, small molecule delta-isoform-selective PI3 kinase inhibitor
Molecular Target Phosphoinositide 3-kinase (PI3K) delta
Mechanism of ActionPhosphoinositide 3-kinase (PI3K) delta inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today